PubMed Health⌕ Search

Biomedical subjects

B H Sarter

Publications and source records attributed to B H Sarter.

8 recordsLinked to original sources
PubMed1999

Antidromic reciprocating tachycardia in patients with paraseptal accessory pathways: importance of critical delay in the reentry circuit.

Previous studies in patients with antidromic reciprocating tachycardia (ART) have observed a critical anatomic requirement (> 4 cm) between an antegrade bypass tract limb and a retrograde AV nodal limb. We report two patients with ART utilizing a paraseptal accessory pathway. In both cases, a critical degree of slow conduction within the circuit provides unusual electrophysiologic substrate to overcome the expected anatomical constraints.

Adult↗
PubMed1998

Efficacy of radiofrequency catheter ablation for ventricular tachycardia in healed myocardial infarction.

Radiofrequency catheter ablation has been useful in the treatment of ventricular tachycardia (VT) in selected patients with healed myocardial infarction. Previous studies have demonstrated success rates of 60% to 96% for targeted VT morphologies; however, these studies included patients only after they have had successful mapping procedures and have received radiofrequency lesions. All patients referred for VT ablation from July 1992 to November 1996 were included in this analysis on an intention-to-treat basis. Ninety-five procedures were performed in 66 patients for 77 distinct presentations with tolerated, sustained VT. Fifty-five procedures were successful (58%) and 40 procedures failed. Reasons for procedural failure included failed radiofrequency application despite adequate VT mapping (21 procedures), no tolerated VT induced (12), and aborted procedures due to complications or technical difficulties (7). Fifty-five patients (71%) eventually had a successful VT ablation, although 10 required > 1 procedure. This analysis revealed factors that contribute to failure of VT ablation procedures in addition to inadequate mapping and lesion formation. Procedural difficulties, particularly the inability to induce tolerated VT, frequently prevent successful catheter ablation in patients who present with tolerated, sustained VT.

Aged↗
PubMed1998

Implantable defibrillator diagnostic storage capabilities: evolution, current status, and future utilization.

There has been a rapid and significant evolution in the stored diagnostic information available from implantable cardioverter defibrillators (ICDs). The diagnostic information available in current generation ICDs has greatly enhanced the clinicians' ability to determine the rhythm triggering device therapy as well as to identify potential problems with the ICD system. Furthermore, this information may be useful in identifying triggers of ventricular arrhythmias in patients at high risk for sudden death. The history, evolution, value, and limitations of the stored diagnostic capabilities of implantable defibrillators are discussed.

Arrhythmias, Cardiac↗
PubMed1996

What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction?

OBJECTIVES: This study sought to determine the long-term risk of sudden cardiac death in patients with hemodynamically stable sustained ventricular tachycardia complicating coronary artery disease. BACKGROUND: The prognosis and risk of sudden cardiac death in patients with a history of myocardial infarction and ventricular tachyarrhythmias have not been clearly defined. Prior studies are limited by a short follow-up period and by inclusion of patients with heterogeneous cardiac diseases and presenting arrhythmias. METHODS: A retrospective cohort analysis was performed on data from 124 patients, followed up for a mean of 36 +/- 30 months, who received electrophysiologically guided therapy for hemodynamically stable ventricular tachycardia after remote myocardial infarction. RESULTS: Seventy-eight patients were treated pharmacologically (medical group), and 46 patients underwent map-guided subendocardial resection (surgical group). Nine patients (7.3%) died suddenly, 5 (4.0%) died of noncardiac causes, 9 (7.3%) died of a perioperative complication, and 20 (23.4%) died of other cardiac causes. At 1, 2 and 3 years, sudden death occurred at cumulative rates of 2 +/- 1%, 3 +/- 2% and 7 +/- 3%, whereas total mortality was 20 +/- 4%, 28 +/- 4% and 32 +/- 5% (mean +/- SD). Sudden cardiac death (p = 0.047) and total mortality (p = 0.036) were higher in patients with multivessel disease and were similar for both treatment groups. CONCLUSIONS: Although the overall mortality in postinfarction patients presenting with hemodynamically stable ventricular tachycardia treated with electrophysiologically guided antiarrhythmic therapy is high, the risk of sudden death in these patients appears to be low (average 2.4%/year).

Anti-Arrhythmia Agents↗
PubMed1996

Effect of bundle branch block on local electrogram morphologic features: implications for arrhythmia diagnosis by stored electrogram analysis.

Analysis of stored local ventricular electrogram recordings is a useful diagnostic tool in the evaluation of patients with implantable cardioverter defibrillators. Visual analysis of local electrogram morphologic features has been demonstrated to be useful in distinguishing ventricular tachycardia from supraventricular rhythm. The effect of bundle branch block (BBB) aberration during supraventricular tachycardia on local electrogram morphologic features is not entirely clear. Erroneous diagnoses resulting from a change in electrogram morphologic features with BBB may occur. To determine whether the development of BBB can produce a change in local electrogram morphologic features and whether this change is dependent on the site of recording, we retrospectively reviewed local electrogram recordings from 23 patients who had intermittent BBB during electrophysiologic evaluation of documented or suspected supraventricular tachycardia. Local electrogram recordings from catheters placed in the right ventricular apex and coronary sinus during supraventricular tachycardia with BBB aberrancy were compared with recordings during narrow complex supraventricular tachycardia or normal sinus rhythm. Bipolar recordings were made with a 5 mm interelectrode distance with filter settings at 40 to 400 Hz. Three independent blinded observers defined the paired electrograms as the same or distinctly different. During right BBB a change in electrogram morphologic features was demonstrated in 11 (85%) of 13 recordings from the right ventricular apex and in only 1 (8%) of 12 recordings from the coronary sinus. In contrast, during left BBB a change in electrogram morphologic features was seen in 6 (100%) of 6 recordings from the coronary sinus and in only 1 (8%) of 13 recordings from the right ventricular apex. These results demonstrate that when the described recording techniques are used, a change in local ventricular electrogram morphologic features BBB is predominantly manifest in recording sites ipsilateral to the BBB, whereas recording sites contralateral to the BBB are relatively unaffected. This information may have implications regarding interpretation of stored electrograms when an attempt is made to establish a rhythm diagnosis leading to implantable cardioverter defibrillator therapy.

Adolescent↗
PubMed1996

Bundle branch reentry ventricular tachycardia: an investigation of the circuit with resetting.

We describe a patient with bundle branch reentry ventricular tachycardia with 1:1 VA conduction in whom resetting was performed while obtaining simultaneous recordings from the right ventricular apex (V) and His-bundle electrogram. Both the tachycardia return cycle and the V-His interval demonstrated an increasing reset response, while the His-V interval demonstrated a flat reset response. These reset responses are consistent with a partially excitable gap localizing to the V-His portion of the bundle branch reentry circuit.

Adult↗
PubMed1992

Redefining the role of digoxin in the treatment of atrial fibrillation.

Atrial fibrillation (AF) encompasses a variety of discrete clinical syndromes, including paroxysmal, chronic, acute, and postoperative. Digoxin, long considered the mainstay of therapy for rate control in all types of AF, appears to have only modest electrophysiologic effects, which are mediated primarily by the autonomic nervous system. Digoxin has less potency than the calcium antagonists or beta-blocking drugs with respect to atrioventricular nodal blockade. Although less potent than calcium antagonists or beta-blocking drugs on the atrioventricular node, digoxin provides positive inotropic support, whereas the other 2 agents can suppress left ventricular function. Thus, digoxin is the agent of choice in patients with AF in the setting of significant left ventricular dysfunction. However, in the absence of left ventricular dysfunction, digoxin should be considered second-line therapy for the treatment of all AF syndromes.

Acute Disease↗